Decision Diagnostics (Decision Diagnostics) Capital Expenditure : $-0.04 Mil (TTM As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Decision Diagnostics's cash flow for capital expenditures for the three months ended in Sep. 2021 was $-0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.04 Mil.

Decision Diagnostics Capital Expenditure Historical Data

The historical data trend for Decision Diagnostics's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics Capital Expenditure Chart

Decision Diagnostics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec17

Dec18

Dec19

Dec20

Capital Expenditure

Get a 7-Day Free Trial

-0.05

-0.12

-0.09

-0.12

Decision Diagnostics Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Capital Expenditure	Get a 7-Day Free Trial															-0.02	-	-0.01	-0.03	-

Decision Diagnostics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

Decision Diagnostics (Decision Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361

Website

http://www.decisiondiagnostics.co

Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.

Executives

Keith Berman	director, officer: Secretary	2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich	director	765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox	director, officer: President